23andMe Holding Co. is a consumer genetics testing company with two segments: Consumer & Research Services and Therapeutics. The former offers an array of genetic reports, while the latter focuses on drug development and discovery of novel therapies. The company has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited for drug research and development.